Kimitaka Akaike

729 total citations
26 papers, 438 citations indexed

About

Kimitaka Akaike is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Kimitaka Akaike has authored 26 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in Kimitaka Akaike's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Kimitaka Akaike is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (3 papers). Kimitaka Akaike collaborates with scholars based in Japan and United States. Kimitaka Akaike's co-authors include Takuro Sakagami, Sho Saeki, Yusuke Tomita, Koichi Saruwatari, Takayuki Jodai, Tokunori Ikeda, Shinya Sakata, Shinji Iyama, Ryo Sato and Shiho Ishizuka and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cancers.

In The Last Decade

Kimitaka Akaike

21 papers receiving 432 citations

Peers

Kimitaka Akaike
Takayuki Jodai Japan
Yueping Jin China
Lorenzo Belluomini Italy
Chuanliang Peng China
Janine Ziemons Netherlands
Bronwen J. Mayo Australia
Xiaosun Liu China
JoAnn Lim United States
George Basdanis Greece
Mark Mattar United States
Takayuki Jodai Japan
Kimitaka Akaike
Citations per year, relative to Kimitaka Akaike Kimitaka Akaike (= 1×) peers Takayuki Jodai

Countries citing papers authored by Kimitaka Akaike

Since Specialization
Citations

This map shows the geographic impact of Kimitaka Akaike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimitaka Akaike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimitaka Akaike more than expected).

Fields of papers citing papers by Kimitaka Akaike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimitaka Akaike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimitaka Akaike. The network helps show where Kimitaka Akaike may publish in the future.

Co-authorship network of co-authors of Kimitaka Akaike

This figure shows the co-authorship network connecting the top 25 collaborators of Kimitaka Akaike. A scholar is included among the top collaborators of Kimitaka Akaike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimitaka Akaike. Kimitaka Akaike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Okabayashi, Hiroko, Kimitaka Akaike, Shohei Hamada, et al.. (2025). Case Report: Tattoo sarcoidosis with epithelioid cell granuloma positive for Propionibacterium acnes. Frontiers in Medicine. 12. 1552114–1552114. 1 indexed citations
3.
Saruwatari, Koichi, Seitaro Oda, Shinya Shiraishi, et al.. (2024). Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancer. Respiratory Investigation. 62(6). 1072–1078.
4.
Hamada, Shohei, Kimitaka Akaike, Hiroko Okabayashi, et al.. (2024). The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. Scientific Reports. 14(1). 4039–4039. 1 indexed citations
5.
6.
7.
Akaike, Kimitaka, Shinji Iyama, Yusuke Tomita, et al.. (2023). Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy. Internal Medicine. 62(17). 2521–2525. 1 indexed citations
8.
Akaike, Kimitaka, Koichi Saruwatari, Kosuke Fujino, et al.. (2022). Clinical impact of SUVmax of interstitial lesions in lung cancer patients with interstitial lung disease who underwent pulmonary resection. Journal of Thoracic Disease. 14(10). 3801–3810. 2 indexed citations
9.
Tomita, Yusuke, Shinya Sakata, Kentaro Oka, et al.. (2022). Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors. OncoImmunology. 11(1). 2081010–2081010. 70 indexed citations
10.
Tomita, Yusuke, Ryo Sato, Tokunori Ikeda, et al.. (2022). Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer. International Journal of Molecular Sciences. 23(22). 13723–13723.
11.
Ichiyasu, Hidenori, Kazuaki Fukushima, Hiroko Okabayashi, et al.. (2021). Validation of a breath-holding test as a screening test for exercise-induced hypoxemia in chronic respiratory diseases. Chronic Respiratory Disease. 18. 4053437285–4053437285. 10 indexed citations
12.
Tomita, Yusuke, Tokunori Ikeda, Shinya Sakata, et al.. (2020). Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer. Cancer Immunology Research. 8(10). 1236–1242. 161 indexed citations
13.
Akaike, Kimitaka, Hajime Iwagoe, Hiroshi Takahashi, et al.. (2020). Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respiratory Investigation. 59(2). 187–193. 32 indexed citations
14.
Hamada, Shohei, Hidenori Ichiyasu, Hiroshi Takahashi, et al.. (2020). Prognostic impact of pre-existing interstitial lung disease in non-HIV patients withPneumocystispneumonia. ERJ Open Research. 6(2). 306–2019. 7 indexed citations
15.
Sakata, Shinya, Kazuyoshi Nakamura, Hiroko Okabayashi, et al.. (2019). Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin. Internal Medicine. 58(9). 1329–1333.
16.
Akaike, Kimitaka, Koichi Saruwatari, Seitaro Oda, et al.. (2019). Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy. International Journal of Clinical Oncology. 25(4). 681–690. 12 indexed citations
17.
Hamada, Shohei, Hidenori Ichiyasu, Tokunori Ikeda, et al.. (2019). Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer. BMC Pulmonary Medicine. 19(1). 72–72. 30 indexed citations
18.
Akaike, Kimitaka, Koichi Saruwatari, Hiroko Okabayashi, et al.. (2018). Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients. Anticancer Research. 38(11). 6543–6550. 3 indexed citations
19.
Okabayashi, Hiroko, Hidenori Ichiyasu, Kimitaka Akaike, et al.. (2017). Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias. BMC Pulmonary Medicine. 17(1). 134–134. 20 indexed citations
20.
Akaike, Kimitaka, et al.. (2011). [Successful treatment of pleurodesis for seemingly intractable pleural effusion in pleural amyloidosis with rheumatoid arthritis].. PubMed. 49(12). 897–902. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takayuki Jodai Breakdown of academic impact, for papers by Yueping Jin Breakdown of academic impact, for papers by Lorenzo Belluomini Breakdown of academic impact, for papers by Chuanliang Peng Breakdown of academic impact, for papers by Janine Ziemons Breakdown of academic impact, for papers by Bronwen J. Mayo Breakdown of academic impact, for papers by Xiaosun Liu Breakdown of academic impact, for papers by JoAnn Lim Breakdown of academic impact, for papers by George Basdanis Breakdown of academic impact, for papers by Mark Mattar
Rankless by CCL
2026